Fabrazyme - supply shortage
Shortage resolved
agalsidase beta
ShortageHuman
Italian is available via eTranslation, the European Commission's machine translation service.
Translate to Italian | Important information about machine translation
Shortage information
The shortage affecting Fabrazyme has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Fabrazyme
- Supply shortage status
- Shortage resolved
- International non-proprietary name (INN) or common name
- agalsidase beta
- Therapeutic area (MESH)
- Fabry Disease
- Pharmaceutical forms affected
- Powder for concentrate for solution for infusion
- Strengths affected
- 5 mg
- 35 mg
- Availability of alternatives
- No
Key dates
- First published
- Last updated